Brief: Can One Slide Make a Difference in an Investor Presentation?
What motivates investors in their decision-making process? And does addressing potential objections upfront impact their decisions? Dr. Carmen Simon, Chief Science Officer at Emblaze, led a neuroscience study to see how investors and analysts react to risk-related information in a first-call presentation.
Published: Jan 12th, 2022